Related Experiment Video
Updated: Aug 13, 2026
Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
Bone marrow transplantation for the treatment of genetic diseases
1Department of Pediatrics, University of California, San Francisco 94143-0105.
Insights
Bone marrow transplants (BMT) offer life-saving potential for children with genetic diseases like SCID. Careful consideration of risks, benefits, and alternative therapies is crucial for conditions such as beta-thalassemia major.
Area of Science:
- Pediatric Hematology
- Genetic Medicine
- Transplantation Immunology
Background:
- Bone marrow transplantation (BMT) is a potential curative therapy for various pediatric genetic disorders.
- The decision to pursue BMT involves complex factors, including disease pathophysiology, natural history, and treatment alternatives.
- Graft-versus-host disease (GVHD) and conditioning therapy risks necessitate careful patient selection.
Purpose of the Study:
- To outline the critical factors influencing the decision-making process for pediatric bone marrow transplantation in genetic diseases.
- To differentiate BMT candidacy based on disease severity and availability of alternative treatments.
- To highlight the importance of considering long-term outcomes, including quality of life, post-transplant.
Main Methods:
- Review of clinical decision-making criteria for BMT in pediatric genetic disorders.
- Analysis of disease-specific factors influencing BMT efficacy and risk-benefit assessment.
- Evaluation of outcomes for genetic diseases with and without established BMT protocols.
Main Results:
- BMT is a primary option for severe genetic diseases with poor life expectancy (e.g., SCID), even with suboptimal donors.
- For conditions like beta-thalassemia major, BMT requires careful consideration with optimal donors due to existing alternative therapies.
- Demonstrated efficacy of BMT in multisystem genetic diseases (e.g., Hurler's mucopolysaccharidosis) if brain damage is absent; not indicated for all storage diseases.
Conclusions:
- BMT candidacy for pediatric genetic diseases is multifactorial, balancing disease severity against transplant risks and potential benefits.
- Individualized assessment is crucial, considering disease-specific factors, donor availability, and alternative treatments.
- Further research is needed to expand the role of BMT in managing a broader spectrum of genetic disorders.
Abstract:
Consideration of a bone marrow transplant (BMT) for a child with a genetic disease depends upon many factors including the pathophysiology of the disorder, the natural history of the disease, whether an alternative therapy exists and whether a donor is available. Children with disorders such as severe combined immunodeficiency disease (SCID), in which life expectancy is minimal, are obviously candidates for a BMT, even with less than optimal donors, while those with disorders such as beta-thalassemia major, in which an alternative therapy exists, must be considered more carefully and only with an optimal donor. The risks of conditioning therapy, graft-versus-host disease (GVHD), and early death as well as the cost are critical to this decision and must be viewed in light of the potential outcome of a successful BMT and the life expectancy and quality of life with a BMT. For some genetic diseases with multisystem involvement (e.g., Hurler's mucopolysaccharidosis), the efficacy of a BMT has been reasonably demonstrated, providing significant brain damage has not occurred previously. For some other storage-related diseases, there is no place for BMT. Further studies are essential to increase our knowledge as to its potential role in other types of genetic-associated diseases.
Related Concept Videos
00:59Gene Therapy
00:59Gene Therapy
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:22Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:24Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...